Onconetix, Inc. (ONCO) (CIK 0001782107) (ONCO)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jun. 15, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 15, 2026 | CORRESP | Neutral/Informational | Moderate | Onconetix, Inc. has submitted a request to the U.S. Securities and Exchange Commission for the acceleration of the effectiveness of their Registration Statement on Form S-1, which… | Read Filing EDGAR |
| Jun. 12, 2026 | UPLOAD | Concern from SEC | Moderate | On June 12, 2026, the SEC notified Onconetix, Inc. that it would not review their registration statement filed on June 9, 2026. The SEC emphasized that the company and its managem… | Read Filing EDGAR |
| May. 7, 2026 | CORRESP | Neutral/Informational | Moderate | Onconetix, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, which was filed on April 28, 2026. The co… | Read Filing EDGAR |
| May. 5, 2026 | UPLOAD | Neutral/Informational | Low | On May 5, 2026, the SEC informed David A. White, CEO of Onconetix, Inc., that they will not review the company's registration statement filed on April 28, 2026. The SEC emphasized… | Read Filing EDGAR |
| Dec. 22, 2025 | CORRESP | Neutral/Informational | Moderate | Onconetix, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, which was initially filed on November 4, … | Read Filing EDGAR |